BackResverlogix Overview
Resverlogix Corp.

Resverlogix Return on Equity

Valuation check: RVX.TO's ROE is 10.89%, above the Healthcare sector average of 9.17%.

Get informed when a big investor buys or sells

+ Follow

ROE

10.89%

Return on Equity

10.89%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Resverlogix (RVX.TO) FAQ

Resverlogix (RVX.TO) currently reports a ROE of 10.89%. That is above the Healthcare sector average of 9.17%. Use the charts on this page to explore Resverlogix's ROE history and peer comparisons.

Resverlogix's ROE of 10.89% is higher than the Healthcare sector average of 9.17%. That is roughly 18.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Resverlogix's current 10.89% should be judged against Healthcare norms (sector average: 9.17%) and against RVX.TO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 10.89%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 9.17%. From there, open related valuation or income-statement pages for Resverlogix, and consider following RVX.TO for alerts when major investors trade the stock.

Resverlogix is classified in the Healthcare sector. On ROE, it currently shows 10.89% versus a sector average near 9.17%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RVX.TO with unrelated industries.

Questions & Answers